However, the heterogeneity in ErbB2/3 and FGFR3 expression was observed in lung cancer cells (Fig. 7b, left; Additional file 7: Figure S6), suggesting regulation of their expression by PRMT5/p44 may be lost in some cancer cells and their functions may be redundant in cancer cell growth. The gene discussed is WDR77; the disease is cancer.